Shareholders at an extraordinary general meeting on November 9, 2026, approved a 100-for-1 consolidation of Class A and Class B ordinary shares. The transaction increases the par value from $0.008 to $0.80 per share and reduces authorized shares from 25 billion to 250 million. The split takes effect on November 19, 2026, alongside amendments to the company's articles of association. Lichen International Limited operates in the biotechnology sector.
